Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards subcommittee of the American Academy of Neurology and the American Headache Society

Peer Carsten Tfelt-Hansen

doi:10.1212/01.wnl.0000427909.23467.39

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards subcommittee of the American Academy of Neurology and the American Headache Society

37 Citationer (Scopus)

Abstract

Peer Carsten Tfelt-Hansen, Glostrup, Denmark: According to the recent American Academy of Neurology (AAN) guideline update, a drug can be recommended as possibly effective for migraine prevention if it had demonstrated efficacy in one Class II study.(1) Eight drugs are recommended as possibly effective,(1) and there are several drugs for which I would question the evidence. Due to space limitations, I have chosen just one example.

Originalsprog	Engelsk
Tidsskrift	Neurology
Vol/bind	80
Udgave nummer	9
Sider (fra-til)	869-70
Antal sider	2
ISSN	0028-3878
DOI	https://doi.org/10.1212/01.wnl.0000427909.23467.39
Status	Udgivet - 26 feb. 2013

Adgang til dokumentet

10.1212/01.wnl.0000427909.23467.39

Fingeraftryk

Dyk ned i forskningsemnerne om 'Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards subcommittee of the American Academy of Neurology and the American Headache Society'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards subcommittee of the American Academy of Neurology and the American Headache Society. / Tfelt-Hansen, Peer Carsten.
I: Neurology, Bind 80, Nr. 9, 26.02.2013, s. 869-70.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{544f3c5ce4a1437799bdd26288cb315b,

title = "Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards subcommittee of the American Academy of Neurology and the American Headache Society",

abstract = "Peer Carsten Tfelt-Hansen, Glostrup, Denmark: According to the recent American Academy of Neurology (AAN) guideline update, a drug can be recommended as possibly effective for migraine prevention if it had demonstrated efficacy in one Class II study.(1) Eight drugs are recommended as possibly effective,(1) and there are several drugs for which I would question the evidence. Due to space limitations, I have chosen just one example.",

keywords = "Humans, Migraine Disorders",

author = "Tfelt-Hansen, {Peer Carsten}",

year = "2013",

month = feb,

day = "26",

doi = "10.1212/01.wnl.0000427909.23467.39",

language = "English",

volume = "80",

pages = "869--70",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "9",

}

TY - JOUR

T1 - Evidence-based guideline update

T2 - pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards subcommittee of the American Academy of Neurology and the American Headache Society

AU - Tfelt-Hansen, Peer Carsten

PY - 2013/2/26

Y1 - 2013/2/26

N2 - Peer Carsten Tfelt-Hansen, Glostrup, Denmark: According to the recent American Academy of Neurology (AAN) guideline update, a drug can be recommended as possibly effective for migraine prevention if it had demonstrated efficacy in one Class II study.(1) Eight drugs are recommended as possibly effective,(1) and there are several drugs for which I would question the evidence. Due to space limitations, I have chosen just one example.

AB - Peer Carsten Tfelt-Hansen, Glostrup, Denmark: According to the recent American Academy of Neurology (AAN) guideline update, a drug can be recommended as possibly effective for migraine prevention if it had demonstrated efficacy in one Class II study.(1) Eight drugs are recommended as possibly effective,(1) and there are several drugs for which I would question the evidence. Due to space limitations, I have chosen just one example.

KW - Humans

KW - Migraine Disorders

U2 - 10.1212/01.wnl.0000427909.23467.39

DO - 10.1212/01.wnl.0000427909.23467.39

M3 - Journal article

C2 - 23439705

SN - 0028-3878

VL - 80

SP - 869

EP - 870

JO - Neurology

JF - Neurology

IS - 9

ER -